Stock AFYA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. Afya Limited Nasdaq

Equities

KYG011251066

Real-time Estimate Cboe BZX
Other stock markets
 02:01:02 2024-05-01 pm EDT 		5-day change 1st Jan Change
17.24 USD 0.00% Intraday chart for Afya Limited 0.00% 0.00%
Mar. 15 Afya Q4 Adjusted Earnings, Revenue Rise; Issues 2024 Revenue Guidance MT
Mar. 15 Afya Limited Provides Earnings Guidance for the FY2024 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
JPMorgan Downgrades Afya to Neutral From Overweight, Adjusts Price Target to $23 From $22
MT
Credit Suisse Adjusts Afya's Price Target to $18 From $19, Keeps Outperform Rating
MT
UBS Adjusts Afya Price Target to $18 From $21, Maintains Buy Rating
MT
Credit Suisse Upgrades Afya to Outperform from Neutral, Adjusts Price Target to $19 from $18
MT
UBS Adjusts Afya Price Target to $21 From $27, Maintains Buy Rating
MT
Goldman Sachs Adjusts Afya's Price Target to $19 From $29, Reiterates Buy Rating
MT
Afya : Sustainalytics ESG Risk Rating Is Publicly Available
BU
Afya : Sustainalytics ESG Risk Rating is Publicly Available
PU
AFYA : Morgan Stanley Downgrades Afya to Equalweight from Overweight, Adjusts Price Target to $28.50 from $32
MT
AFYA : UBS Upgrades Afya to Buy From Neutral, Citing Recent Sell-Off, Resiliency, Cash Generation; Price Target to $27 From $29.50
MT
AFYA : JPMorgan Upgrades Afya to Overweight From Neutral; Price Target is $34
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AFYA Stock
  4. Stock
  5. News Afya Limited
  6. Analyst Reco.